Phase 2 Trial of 5-Strain Probiotic Formulation in HR-Positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
Hormone Receptor-Positive Breast Carcinoma
Enrolment: 38 · Results not recorded
Nutraceutical
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Hormone Receptor-Positive Breast Carcinoma
Enrolment: 38 · Results not recorded
Healthy Volunteers
Enrolment: 100 · Results not recorded
PCOS- Polycystic Ovary Syndrome
Enrolment: 40 · Results not recorded
Healthy Newborn Infants
Enrolment: 125 · Results not recorded
Papillomavirus Infections
Enrolment: 21 · Results not recorded
Inflammatory Bowel Disease · Ulcerative Colitis
Enrolment: 50 · Results not recorded
Athlete · Sedentary Behavior
Enrolment: 27 · Results not recorded
Healthy · Obesity · Nutrition · Vitamin D Deficiency
Enrolment: 120 · Results not recorded
ADHD · Gastrointestinal · Emotion Regulation Abilities
Enrolment: 174 · Results not recorded
Aging
Enrolment: 29 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Acute radiation-induced intestinal injury and diarrhoea
Synbiotic supplementation did not prevent diarrhoea but significantly reduced its severity, neutrophil accumulation and lipid peroxidation and improved histology and weight loss.
Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.